Julie Schulz, MD, MPH, Physician Executive, Product leader, and VP of Product, and Michael Dovidio, PharmD, Product Manager at Avalon Healthcare Solutions, discuss why leveraging cardiometabolic lab values instead of BMI to determine coverage for GLP-1 drugs would improve prescription allocation for diabetic and obese patients. ...
Disparities in Cardiometabolic Disease (CMD)
Advertisement
Metabolic syndrome affects patients with psoriatic arthritis and rheumatoid arthritis differently.
Having health insurance does not mitigate the impact of racial and ethnic disparities on glycemic control among US adults.
Pharmacist-led, patient-specific interventions reduced HbA1c concentrations in Hispanic patients.
Short-term use of NSAIDs could lead to an increased risk of first-time hospitalization for heart failure in diabetic patients
Many Medicaid patients with heart failure and diabetes did not receive adequate follow-up after hospitalization.
Overweight or obese children are more likely to be at risk for type 2 diabetes, CVD, cancer, and osteoarthritis.
Cardiovascular hospitalization rates are rising for lower-income individuals with type 2 diabetes.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.